Evolution of practices regarding COVID-19 treatment in France during the first wave: results from three cross-sectional surveys (March to June 2020)

J Antimicrob Chemother. 2021 Apr 13;76(5):1372-1374. doi: 10.1093/jac/dkaa564.

S Rolland^{1

2}, D Lebeaux^{3

4}, P Tattevin⁵, O Launay^{1

6}, L B Luong Nguyen¹

¹ INSERM CIC 1417 Cochin Pasteur, AP-HP, Hôpital Cochin, 75014 Paris, France.
² Infectious Diseases Department, Cavale Blanche University Hospital, 29200 Brest, France.
³ Université de Paris, F-75006 Paris, France.
⁴ Service de Microbiologie, Unité Mobile d'Infectiologie, AP-HP, Hôpital Européen Georges Pompidou, 75015 Paris, France.
⁵ Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, 35000 Rennes, France.
⁶ Université de Paris, Faculté de médecine Paris Descartes, INSERM CIC 1417, F-CRIN, I REIVAC, 75014 Paris, France.

No abstract available

MeSH terms